The result is a three-tier eligibility framework, and which tier you fall under matters less than the fact that meeting any one of them gives you the same $50 per month medication coverage
Its being studied for both diabetes and weight management, with an FDA decision expected in late 2026
Counter frozen meals are widely available at over 1,650 Target locations, Kroger, and Lidl stores, as of March 2026
Pharmaceutical giants such as Novo Nordisk and Eli Lilly are pouring billions into production expansion to meet this surge
There is no reason not to apply this logic to probiotics as well
The Coming Wave of GLP-1 Competition The global success of GLP-1s has reshaped the metabolic disease landscape, driving unprecedented demand across diabetes, obesity, and adjacent indications